XPR – Lifestyle Demo
Author:
Wellgistics Health, Inc.
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
March 23, 2026
Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share
March 19, 2026
Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction
March 13, 2026
Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities
March 11, 2026
Wellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization Mandate
March 5, 2026